GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/Sedation Strategy Influences Aspiration Risk After PEG : Frontline Gastroenterol | May 2026
38

Sedation Strategy Influences Aspiration Risk After PEG : Frontline Gastroenterol | May 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated May 1, 2026

Introduction

Percutaneous Endoscopic Gastrostomy is widely performed for long-term enteral nutritional support in patients with neurological disease, dysphagia and chronic debilitating illness. Aspiration pneumonia remains one of the most important early complications following PEG insertion and contributes substantially to post-procedural morbidity and mortality. However, the influence of sedation and local anaesthesia practices on aspiration risk has remained poorly defined at a population level.

Problem Statement

Considerable variation exists in endoscopic sedation and throat anaesthesia practices during PEG insertion across institutions. Whether specific sedation approaches independently increase post-PEG aspiration pneumonia risk has not previously been evaluated in a large real-world multicentre cohort.

Summary

This large retrospective population-based study analyzed more than 33,000 adult patients undergoing PEG insertion across England between 2016 and 2021. Investigators integrated Hospital Episode Statistics with National Endoscopy Database provider-level sedation practices to evaluate associations between procedural anaesthesia strategies and aspiration pneumonia occurring within seven days of PEG placement.

Substantial variation in sedation practice was observed across providers. Nearly half predominantly used combined midazolam-opioid sedation, while others favored midazolam alone, local anaesthetic throat spray or propofol/general anaesthesia approaches. Stroke represented the most common indication for PEG insertion and was associated with the highest baseline aspiration risk compared with other clinical indications.

The strongest associations with post-PEG aspiration pneumonia were observed among providers predominantly using propofol/general anaesthesia and those combining midazolam with local anaesthetic throat spray. In contrast, aspiration risk was substantially lower among providers using midazolam alone or combined with opioids without routine throat spray. These findings suggest that suppression of protective airway reflexes may play a central role in aspiration pathogenesis during PEG procedures.

The association with local anaesthetic throat spray is particularly notable because topical pharyngeal anaesthesia may impair laryngeal sensation and cough reflexes in already vulnerable dysphagic patients. Similarly, deeper sedation with propofol or general anaesthesia likely further compromises airway protection and swallowing coordination during and immediately after PEG insertion.

Additional procedural and patient-level risk factors included low provider procedural volume, advanced age and emergency hospital admission. Providers performing fewer than 23 PEG procedures annually demonstrated higher aspiration rates, suggesting an important volume-outcome relationship and potential benefit of procedural centralization or enhanced training pathways.

Clinically, the findings challenge routine use of aggressive sedation strategies during PEG insertion, particularly in frail neurological populations already predisposed to aspiration. The data support more individualized sedation approaches balancing patient comfort with preservation of airway protective reflexes.

Overall, this large national study demonstrates that sedation and local anaesthesia practices substantially influence aspiration pneumonia risk following PEG insertion. The findings have important implications for endoscopy sedation protocols and suggest that minimizing deep sedation and cautious use of local anaesthetic throat spray may improve procedural safety in high-risk PEG populations.

Related Q&A

39

3D-Printed Distal Caps for ESD: Clinical and Translational Gastroenterology | May 2026

Conventional Method Commercial distal attachment caps are routinely used during Endoscopic Submucosal Dissection to improve visualization, tissue traction, and procedural stability. Although effective, these caps are commercially manufactured,...

40

Post-ERCP Bleeding Risks Clarified in Large Meta-analysis : Gastrointest Endosc | May 2026

Introduction Endoscopic retrograde cholangiopancreatography (ERCP) is a cornerstone therapeutic procedure in pancreatobiliary disease but carries a risk of clinically significant bleeding, particularly following therapeutic interventions such as sphincterotomy....

41

Predictors of Post-ERCP Bleeding Identified in Large Meta-analysis : Gastrointest Endosc | May 2026

Introduction Endoscopic retrograde cholangiopancreatography (ERCP) is an essential therapeutic procedure in pancreatobiliary disease but remains associated with important adverse events, including postprocedural bleeding. Although bleeding occurs relatively infrequently,...

42

International Consensus Defines Best Practices for EUS-Guided Gastroenterostomy : Gastrointestinal Endoscopy | May 2026

Introduction Endoscopic ultrasound–guided gastroenterostomy (EUS-GE) has rapidly emerged as an important minimally invasive option for the management of gastric outlet obstruction, offering an alternative to surgical bypass and...

43

EUS-Directed Transenteric ERCP Expands Options in Surgically Altered Anatomy : Gastrointestinal Endoscopy | May 2026

Introduction Biliary intervention in patients with surgically altered anatomy remains one of the most technically challenging areas in therapeutic endoscopy. Conventional enteroscopy-assisted ERCP is often limited by difficult...

44

Same-Day Discharge After G-POEM Appears Safe in Selected Patients | Gastrointestinal Endoscopy

Introduction Gastric per oral endoscopic myotomy (G-POEM) has emerged as an effective minimally invasive therapy for refractory gastroparesis. However, post-procedural care remains variable across centers, with no clear...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer